好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Acute Regional Infarct Topography and Hemorrhagic Transformation Risk After Endovascular Thrombectomy: A Multicenter Bayesian Analysis
Cerebrovascular Disease and Interventional Neurology
P2 - Poster Session 2 (8:00 AM-9:00 AM)
13-007
To identify associations between pre-treatment infarct location and hemorrhagic transformation (HT) after endovascular thrombectomy (EVT).
As more patients with stroke are treated with EVT, including those with larger cores, understanding the pathophysiology of HT is becoming increasingly important. Pre-EVT infarct topography may have implications for acute decisions (e.g. stenting) and for post-EVT care (e.g. antithrombotics, blood pressure goals).

Consecutive large vessel occlusion patients with pre-EVT MRI were identified from two centers (2011-2019). Acute infarcts were extracted through a deep learning-enabled pipeline from DWI and spatially normalized. Brains were parcellated (atlas-defined 94 cortical regions, 14 subcortical nuclei, 20 white matter tracts) and reduced to ten principal lesion patterns using unsupervised dimensionality reduction techniques (non-negative matrix factorization). Binary HT, defined as ECASS PH1 or PH2, was modeled via Bayesian regression, using lesion patterns as inputs, and controlling for total lesion volume, age, sex, initial NIH Stroke Scale (NIHSS), thrombolysis, good reperfusion (TICI 2b-3), acute stenting, last known well-to-puncture time, and other risk factors.

567 patients (mean age 69 ±15 years; 45% female) had pre-EVT DWI without significant artifacts that underwent lesion segmentation and registration, with median NIHSS 16 (IQR 11-20) and mean total infarct volume was 22.5 ±36.7mL. Thrombolysis was administered in 51%, good reperfusion was achieved in 83%, and HT occurred in 10% of patients. Lesion locations significantly related to HT involved bilateral caudate, putamen, pallidum, and anterior thalamic radiation; and, right more than left thalamus, corticospinal tract, and inferior fronto-occipital fasciculus (area under the curve: 0.73).

These data from a large, multicenter cohort with precise MRI-defined infarcts underscore the risk of specific brain regions infarcted for HT after EVT. Understanding this pathophysiology can inform not only current clinical practice but also the development of future novel therapeutics to prevent HT as more patients with large cores undergo EVT.

Authors/Disclosures
Anna K. Bonkhoff, MD (Mass General Brigham)
PRESENTER
Dr. Bonkhoff has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NeuroImage Clinical (Elsevier).
Markus D. Schirmer, PhD (Massachusetts General Hospital) The institution of Dr. Schirmer has received research support from National Institute of Aging.
Christopher G. Favilla, MD (University of Pennsylvania) The institution of Dr. Favilla has received research support from National Institutes of Health. The institution of Dr. Favilla has received research support from American Heart Association. The institution of Dr. Favilla has received research support from OpenWater, Inc..
Alvin Das, MD Dr. Das has nothing to disclose.
Adam Dmytriw (Massachusetts General Hospital) Adam Dmytriw has nothing to disclose.
Rajiv Gupta, MD Dr. Gupta has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Idorsia, Inc.. Dr. Gupta has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic, Inc.. Dr. Gupta has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer HealthCare, LLC. Dr. Gupta has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BrainTale, Inc.. Dr. Gupta has received personal compensation in the range of $0-$499 for serving as a Consultant for Agfa HealthCare Inc.. Dr. Gupta has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siemens Medical Solutions, USA. Dr. Gupta has received personal compensation in the range of $0-$499 for serving as a Consultant for Canon Inc.. Dr. Gupta has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for MQB Law. Dr. Gupta has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for US Attorney, District of Colorado. Dr. Gupta has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Sulloway & Hollis, P.L.L.C.. The institution of Dr. Gupta has received research support from Samsung.
James Rabinov James Rabinov has nothing to disclose.
Christopher Stapleton (Massachusetts General Hospital) Christopher Stapleton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Johnson & Johnson MedTech. Christopher Stapleton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll Circulation, Inc.. Christopher Stapleton has received publishing royalties from a publication relating to health care.
Thabele M. Leslie-Mazwi, MD Dr. Leslie-Mazwi has a non-compensated relationship as a Board Member with American Brain Foundation that is relevant to AAN interests or activities. Dr. Leslie-Mazwi has a non-compensated relationship as a Council Member with American Heart Association/American Stroke Association that is relevant to AAN interests or activities.
Claus Simonsen (Aarhus University Hospital) Claus Simonsen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizer.
Aman Patel Aman Patel has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Microvention. Aman Patel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Stryker. Aman Patel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Aman Patel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Penumbra.
Eng Lo, MD (Massachusetts General Hospital) Eng Lo, MD has nothing to disclose.
Natalia S. Rost, MD, MPH, FAAN, FAHA (Massachusetts General Hospital) Dr. Rost has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for 好色先生. Dr. Rost has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke - AHA/ASA Journal. The institution of Dr. Rost has received research support from NIH. Dr. Rost has received publishing royalties from a publication relating to health care.
Robert W. Regenhardt, MD, PhD Dr. Regenhardt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genomadix. Dr. Regenhardt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rapid Medical. Dr. Regenhardt has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Johnson and Bell Trial Lawyers. Dr. Regenhardt has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Buckley, Theroux, Kline, & Cooley Trial Lawyers. The institution of Dr. Regenhardt has received research support from National Institutes of Health. The institution of Dr. Regenhardt has received research support from Society of Vascular and Interventional Neurology. The institution of Dr. Regenhardt has received research support from Heitman Foundation.